 "Marksans Pharma surges on strong Q2 results")
Shares of Marksans Pharma has surged 6% to Rs 64 on NSE after reporting a strong 56% year-on-year jump in net profit at Rs 31.16 crore for the quarter ended September 2014 (Q2), on back of healthy sales. The pharmaceutical company had profit of Rs 20 crore in the same quarter last fiscal.
Net sales grew 30% to Rs 210 crore in September quarter as against Rs 161 crore in the corresponding quarter of previous year.
EBITDA or operating profit margin grew to 24.2% from 18.38% for the second quarter.
Net sales grew 30% to Rs 210 crore in September quarter as against Rs 161 crore in the corresponding quarter of previous year.
EBITDA or operating profit margin grew to 24.2% from 18.38% for the second quarter.
The stock opened at Rs 61.25 and touched a high of Rs 66.25 on NSE. The trading volumes on the counter more-than-doubled with a combined 10.33 million shares changed hands till 1250 hours on NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%